Total Payments
$308.01
2024 Payments
$210.21
Companies
7
Transactions
12
Medicare Patients
3,151
Medicare Billing
$542,606
Payment Breakdown by Category
Food & Beverage$291.77 (94.7%)
Education$16.24 (5.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $291.77 | 11 | 94.7% |
| Education | $16.24 | 1 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $89.89 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $64.58 | 2 | $0 (2023) |
| ABBVIE INC. | $56.68 | 2 | $0 (2024) |
| Gilead Sciences, Inc. | $43.73 | 2 | $0 (2024) |
| Shionogi Inc | $19.91 | 1 | $0 (2024) |
| Theravance Biopharma Inc. | $16.98 | 1 | $0 (2017) |
| Insmed, Inc. | $16.24 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $210.21 | 8 | AIMMUNE THERAPEUTICS, INC. ($89.89) |
| 2023 | $64.58 | 2 | Merck Sharp & Dohme LLC ($64.58) |
| 2022 | $16.24 | 1 | Insmed, Inc. ($16.24) |
| 2017 | $16.98 | 1 | Theravance Biopharma Inc. ($16.98) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/01/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Infections and Infectious Diseases | ||||||
| 09/11/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: GI | ||||||
| 07/24/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.49 | General |
| 07/10/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: GI | ||||||
| 06/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.24 | General |
| 01/25/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: GI | ||||||
| 09/21/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/08/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/05/2022 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 03/24/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Infectious Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 853 | 1,829 | $566,630 | $177,862 |
| 2022 | 9 | 891 | 1,926 | $418,165 | $150,110 |
| 2021 | 9 | 760 | 1,762 | $318,852 | $125,891 |
| 2020 | 5 | 647 | 1,480 | $236,597 | $88,743 |
Total Patients
3,151
Total Services
6,997
Medicare Billing
$542,606
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 234 | 749 | $193,242 | $70,622 | 36.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 244 | 252 | $125,748 | $34,593 | 27.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 155 | 462 | $82,698 | $28,461 | 34.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 34 | 134 | $94,470 | $23,139 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 133 | $42,560 | $12,821 | 30.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 60 | 60 | $20,460 | $6,198 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 24 | $5,472 | $1,497 | 27.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 15 | $1,980 | $530.92 | 26.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 276 | 1,095 | $171,015 | $62,080 | 36.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 196 | 209 | $89,256 | $32,346 | 36.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 108 | 253 | $57,267 | $20,763 | 36.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 135 | $39,906 | $13,282 | 33.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 91 | 95 | $29,648 | $10,384 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 73 | $13,629 | $5,317 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $9,557 | $3,109 | 32.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 14 | 21 | $5,520 | $1,987 | 36.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 21 | 21 | $2,367 | $844.14 | 35.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 324 | 1,268 | $182,592 | $73,246 | 40.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 203 | 210 | $57,540 | $22,376 | 38.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 71 | 73 | $29,346 | $11,099 | 37.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 101 | $26,159 | $10,203 | 39.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 38 | 39 | $7,995 | $3,251 | 40.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $5,408 | $2,198 | 40.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 13 | 19 | $4,940 | $1,945 | 39.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 21 | 22 | $2,310 | $863.11 | 37.4% |
About Dr. John Han, M.D
Dr. John Han, M.D is a Infectious Disease healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285685321.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Han, M.D has received a total of $308.01 in payments from pharmaceutical and medical device companies, with $210.21 received in 2024. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($291.77).
As a Medicare-enrolled provider, Han has provided services to 3,151 Medicare beneficiaries, totaling 6,997 services with total Medicare billing of $542,606. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Jacksonville, FL
- Active Since 05/13/2006
- Last Updated 07/03/2024
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285685321
Products in Payments
- VOWST (Biological) $89.89
- DIFICID (Drug) $64.58
- AVYCAZ (Drug) $56.68
- Fetroja (Drug) $19.91
- VIBATIV (Drug) $16.98
- Arikayce (Drug) $16.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Jacksonville
Dr. Pablo Pella, Md, MD
Infectious Disease — Payments: $139,265
Infectious Disease $139,265
Daniela Chiriboga-Salazar, M.d, M.D
Infectious Disease — Payments: $77,648
Infectious Disease $77,648
Mohammed Reza, Md, MD
Infectious Disease — Payments: $56,351
Infectious Disease $56,351
Robert Catalla, Md, MD
Infectious Disease — Payments: $48,830
Infectious Disease $48,830
Shalika Katugaha, Md, MD
Infectious Disease — Payments: $40,883
Infectious Disease $40,883
Ivan Guerrero, Md, MD
Infectious Disease — Payments: $26,872
Infectious Disease $26,872